{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:14:57Z","timestamp":1790936097315,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.it.2004.03.006","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T07:12:17Z","timestamp":1082531537000},"page":"295-305","source":"Crossref","is-referenced-by-count":228,"title":["Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u2018Type 1\u2019 inflammatory gene expression"],"prefix":"10.1016","volume":"25","author":[{"given":"Wook","family":"Lew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2004.03.006_BIB1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.it.2004.03.006_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.it.2004.03.006_BIB4","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.it.2004.03.006_BIB5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.it.2004.03.006_BIB6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2004.03.006_BIB8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-5699(98)01381-4","article-title":"The pathogenesis of psoriasis: immunological facts and speculations","volume":"20","author":"Bos","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.it.2004.03.006_BIB9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-2133.2002.04760.x","article-title":"Novel immune-based therapies for psoriasis","volume":"146","author":"Kirby","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0167-5699(97)01116-X","article-title":"Langerhans cells may trigger the psoriatic disease process via production of nitric oxide","volume":"18","author":"Morhenn","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.it.2004.03.006_BIB11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1172\/JCI8633","article-title":"Skin innate immune system in psoriasis: friend or foe?","volume":"104","author":"Nickoloff","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.it.2004.03.006_BIB13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5858\/2003-127-178-IIRRIN","article-title":"Innate immune-related receptors in normal and psoriatic skin","volume":"127","author":"Curry","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(00)00120-1","article-title":"Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system","volume":"24","author":"Nickoloff","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.it.2004.03.006_BIB15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.it.2004.03.006_BIB16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","article-title":"The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-\u03b3, interleukin-2, and tumor necrosis factor-\u03b1, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients","volume":"113","author":"Austin","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004030000167","article-title":"Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory\/effector type 1 immunophenotype","volume":"292","author":"Friedrich","year":"2000","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.it.2004.03.006_BIB19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin \u03b1E\u03b27 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2004.03.006_BIB21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.0022-202x.2001.01494.x","article-title":"Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris","volume":"117","author":"Vollmer","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB22","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.91.20.9282","article-title":"CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V\u03b23 and\/or V\u03b213.1 genes","volume":"91","author":"Chang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2004.03.006_BIB23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2133.1997.tb03715.x","article-title":"Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity","volume":"137","author":"Snowden","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI6910","article-title":"Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions","volume":"104","author":"Trepicchio","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-5699(95)80132-4","article-title":"Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?","volume":"16","author":"Valdimarsson","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.it.2004.03.006_BIB28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jaut.1997.0175","article-title":"Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4","volume":"11","author":"Bachelez","year":"1998","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2004.03.006_BIB29","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB30","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.onc.1206262","article-title":"Identification of NF-\u03baB-regulated genes induced by TNF\u03b1 utilizing expression profiling and RNA interference","volume":"22","author":"Zhou","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2004.03.006_BIB31","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2004.03.006_BIB32","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1093\/nar\/25.21.4346","article-title":"Convergence of TNF\u03b1 and IFN\u03b3 signalling pathways through synergistic induction of IRF-1\/ISGF-2 is mediated by a composite GAS\/\u03baB promoter element","volume":"25","author":"Pine","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2004.03.006_BIB33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.it.2004.03.006_BIB34","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.170.11.5438","article-title":"IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14\/p40 transgenic mice: evidence for enhanced cutaneous immunity","volume":"170","author":"Kopp","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of IL-23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB36","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1471-4906(03)00067-X","article-title":"Novel IL-12 family members shed light on the orchestration of Th1 responses","volume":"24","author":"Brombacher","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4\u2013Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines","volume":"94","author":"Nestle","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/1523-1747.ep12465237","article-title":"Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells","volume":"96","author":"Morganroth","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-065X.2003.00075.x","article-title":"Lymphoid organ development and cell migration","volume":"195","author":"Cyster","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2004.03.006_BIB44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1471-4906(01)01863-4","article-title":"Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation","volume":"22","author":"Buckley","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1074-7613(00)80198-3","article-title":"The temporal importance of TNF\u03b1 expression in the development of diabetes","volume":"12","author":"Green","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.it.2004.03.006_BIB46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2004.03.006_BIB47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-\u03b1\/\u03b2 signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.it.2004.03.006_BIB48","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis is a new animal model: essential role for resident T cells and tumor necrosis factor-\u03b1","volume":"199","author":"Boyman","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1523-1747.ep12335758","article-title":"T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice","volume":"109","author":"Gilhar","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB51","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200318986","article-title":"Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model","volume":"112","author":"Villadsen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"Blumberg","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.it.2004.03.006_BIB53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.it.2004.03.006_BIB54","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2004.03.006_BIB55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45 \u03b2 required in cytokine-induced, but not TCR-induced, IFN-\u03b3 production","volume":"2","author":"Yang","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2004.03.006_BIB56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.192.5.705","article-title":"Macrophage inflammatory protein 3\u03b1 is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting langerhans cell precursors","volume":"192","author":"Dieu-Nosjean","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB57","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB58","first-page":"820","article-title":"Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis","volume":"144","author":"Nickoloff","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2004.03.006_BIB59","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2001.01316.x","article-title":"Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis","volume":"116","author":"Kuroda","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00015559850135779","article-title":"Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity","volume":"78","author":"Bonifati","year":"1998","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.it.2004.03.006_BIB62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.167.2.670","article-title":"Detection of transforming growth factor \u03b1 in normal, malignant, and hyperproliferative human keratinocytes","volume":"167","author":"Gottlieb","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.2916128","article-title":"Overexpression of transforming growth factor \u03b1 in psoriatic epidermis","volume":"243","author":"Elder","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.it.2004.03.006_BIB64","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1111\/1523-1747.ep12505661","article-title":"Epidermal growth factor\/transforming growth factor a receptors and psoriasis","volume":"95","author":"King","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000372-199604000-00010","article-title":"Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases","volume":"18","author":"Piepkorn","year":"1996","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.it.2004.03.006_BIB66","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1523-1747.ep12476485","article-title":"Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis","volume":"96","author":"Krane","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.it.2004.03.006_BIB67","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.175.4.1081","article-title":"The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor","volume":"175","author":"Krane","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2004.03.006_BIB68","first-page":"1619","article-title":"Altered expression of keratinocyte growth factor and its receptor in psoriasis","volume":"151","author":"Finch","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2004.03.006_BIB69","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-\u03b3","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490604000985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490604000985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T17:58:44Z","timestamp":1623866324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490604000985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1471490604000985"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2004.03.006","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}